In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00272" target="_blank" rel="noopener">Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study</a>" by Bourhis, et al published September 03, 2025 TRANSCRIPT

<description>&lt;p&gt;In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "&lt;a href= "https://ascopubs.org/doi/10.1200/JCO-25-00272" target="_blank" rel="noopener"&gt;Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study&lt;/a&gt;" by Bourhis, et al published September 03, 2025&lt;/p&gt; &lt;p&gt;&lt;span style= "text-decoration: underline;"&gt;&lt;strong&gt;TRANSCRIPT&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt; &lt;/p&gt;</description>

Journal of Clinical Oncology (JCO) Podcast

JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

Description